,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1367603,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,176988.0,COL-109,https://ctdbase.org/detail.go?type=gene&acc=176988,,,176988,col-109,6239,Caenorhabditis elegans,Mianserin results in decreased expression of COL-109 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
1,1367604,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,177901.0,COL-124,https://ctdbase.org/detail.go?type=gene&acc=177901,,,177901,col-124,6239,Caenorhabditis elegans,Mianserin results in increased expression of COL-124 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
2,1386226,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,163786.0,SASS6,https://ctdbase.org/detail.go?type=gene&acc=163786,,,163786,SASS6,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of SASS6 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of SASS6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
3,1460059,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,665419.0,RAB11B-PS2,https://ctdbase.org/detail.go?type=gene&acc=665419,,,665419,Rab11b-ps2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of RAB11B-PS2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
4,1551169,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,1666.0,DECR1,https://ctdbase.org/detail.go?type=gene&acc=1666,,,1666,DECR1,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of DECR1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
5,1551170,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,26063.0,DECR2,https://ctdbase.org/detail.go?type=gene&acc=26063,,,26063,DECR2,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of DECR2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
6,1445884,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,388403.0,YPEL2,https://ctdbase.org/detail.go?type=gene&acc=388403,,,388403,YPEL2,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of YPEL2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
7,1474071,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2764.0,GMFB,https://ctdbase.org/detail.go?type=gene&acc=2764,,,2764,GMFB,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of GMFB mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
8,1474072,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,431743.0,GMPPAA,https://ctdbase.org/detail.go?type=gene&acc=431743,,,431743,gmppaa,7955,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of GMPPAA mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
9,1447827,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2909.0,ARHGAP35,https://ctdbase.org/detail.go?type=gene&acc=2909,,,2909,ARHGAP35,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ARHGAP35 mRNA,,,PMID:12760830,https://www.ncbi.nlm.nih.gov/pubmed/12760830,12760830,,
10,1496666,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84002.0,B3GNT5,https://ctdbase.org/detail.go?type=gene&acc=84002,,,84002,B3GNT5,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of B3GNT5 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
11,1496667,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84002.0,B3GNT5,https://ctdbase.org/detail.go?type=gene&acc=84002,,,84002,B3GNT5,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of B3GNT5 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
12,1496795,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9128.0,PRPF4,https://ctdbase.org/detail.go?type=gene&acc=9128,,,9128,PRPF4,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PRPF4 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
13,1517670,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,115827.0,RAB3C,https://ctdbase.org/detail.go?type=gene&acc=115827,,,115827,RAB3C,10116,Rattus norvegicus (Norway rat),Cocaine results in increased expression of RAB3C mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
14,1608403,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,4155.0,MBP,https://ctdbase.org/detail.go?type=gene&acc=4155,,,4155,MBP,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of MBP protein,,,PMID:20584760,https://www.ncbi.nlm.nih.gov/pubmed/20584760,20584760,,
15,1608404,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,4170.0,MCL1,https://ctdbase.org/detail.go?type=gene&acc=4170,,,4170,MCL1,9606,Homo sapiens (human),Dieldrin results in increased expression of MCL1 mRNA,,,PMID:31068361,https://www.ncbi.nlm.nih.gov/pubmed/31068361,31068361,,
16,1608405,969491,Comparative Toxicogenomics Database (CTD),Dieldrin,D004026,Dieldrin,https://ctdbase.org/detail.go?type=chem&acc=D004026,4171.0,MCM2,https://ctdbase.org/detail.go?type=gene&acc=4171,,,4171,MCM2,27706,Micropterus salmoides (largemouth bass),Dieldrin results in increased expression of MCM2 mRNA,,,PMID:20438755,https://www.ncbi.nlm.nih.gov/pubmed/20438755,20438755,,
17,2037453,13943297,Comparative Toxicogenomics Database (CTD),Astragaloside IV,C052064,astragaloside A,https://ctdbase.org/detail.go?type=chem&acc=C052064,2701.0,GJA4,https://ctdbase.org/detail.go?type=gene&acc=2701,,,2701,GJA4,9606,Homo sapiens (human),"Astragaloside A inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of GJA4 protein]",,,PMID:36322813,https://www.ncbi.nlm.nih.gov/pubmed/36322813,36322813,,
18,2037454,13943297,Comparative Toxicogenomics Database (CTD),Astragaloside IV,C052064,astragaloside A,https://ctdbase.org/detail.go?type=chem&acc=C052064,2752.0,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752,GLUL,10116,Rattus norvegicus (Norway rat),Astragaloside A inhibits the reaction [bisphenol A results in decreased activity of GLUL protein],,,PMID:34434659,https://www.ncbi.nlm.nih.gov/pubmed/34434659,34434659,,
19,2037455,13943297,Comparative Toxicogenomics Database (CTD),Astragaloside IV,C052064,astragaloside A,https://ctdbase.org/detail.go?type=chem&acc=C052064,2875.0,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875,GPT,10116,Rattus norvegicus (Norway rat),Astragaloside A inhibits the reaction [cisplatin results in increased expression of GPT protein],,,PMID:30842369,https://www.ncbi.nlm.nih.gov/pubmed/30842369,30842369,,
20,2037456,13943297,Comparative Toxicogenomics Database (CTD),Astragaloside IV,C052064,astragaloside A,https://ctdbase.org/detail.go?type=chem&acc=C052064,2903.0,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903,GRIN2A,10116,Rattus norvegicus (Norway rat),Astragaloside A inhibits the reaction [bisphenol A affects the expression of GRIN2A mrna],,,PMID:34434659,https://www.ncbi.nlm.nih.gov/pubmed/34434659,34434659,,
21,2012786,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,100124700.0,HOTAIR,https://ctdbase.org/detail.go?type=gene&acc=100124700,,,100124700,HOTAIR,9606,Homo sapiens (human),HOTAIR mRNA affects the susceptibility to enzalutamide,,,PMID:26411689,https://www.ncbi.nlm.nih.gov/pubmed/26411689,26411689,,
22,2012787,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,26160.0,IFT172,https://ctdbase.org/detail.go?type=gene&acc=26160,,,26160,IFT172,9606,Homo sapiens (human),Enzalutamide affects the expression of IFT172 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
23,2012788,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,80173.0,IFT74,https://ctdbase.org/detail.go?type=gene&acc=80173,,,80173,IFT74,9606,Homo sapiens (human),Enzalutamide affects the expression of IFT74 mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
24,2012789,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,3479.0,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479,IGF1,9606,Homo sapiens (human),Enzalutamide results in decreased expression of IGF1 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
25,2012790,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,3480.0,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480,IGF1R,9606,Homo sapiens (human),Enzalutamide results in decreased expression of IGF1R mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
26,2012791,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,3569.0,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),Niclosamide inhibits the reaction [IL6 protein results in decreased susceptibility to enzalutamide]|il6 protein results in decreased susceptibility to enzalutamide,,,PMID:25970160,https://www.ncbi.nlm.nih.gov/pubmed/25970160,25970160,,
27,2012806,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,8850.0,KAT2B,https://ctdbase.org/detail.go?type=gene&acc=8850,,,8850,KAT2B,9606,Homo sapiens (human),Enzalutamide affects the expression of KAT2B mRNA,,,PMID:30940724,https://www.ncbi.nlm.nih.gov/pubmed/30940724,30940724,,
28,2012807,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,23028.0,KDM1A,https://ctdbase.org/detail.go?type=gene&acc=23028,,,23028,KDM1A,9606,Homo sapiens (human),KDM1A protein promotes the reaction [enzalutamide results in decreased expression of KLK3 protein]|kdm1a protein promotes the reaction [enzalutamide results in decreased expression of MAP2 mrna]|kdm1a protein promotes the reaction [enzalutamide results in decreased expression of MYO1B mrna]|kdm1a protein promotes the reaction [enzalutamide results in decreased expression of LCP1 mrna]|kdm1a protein promotes the reaction [enzalutamide results in decreased expression of TMCC3 mrna]|kdm1a protein promotes the reaction [enzalutamide results in decreased expression of SLC22A3 mrna]|kdm1a protein promotes the reaction [enzalutamide results in decreased expression of CRYM mrna],,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
29,2012808,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,3800.0,KIF5C,https://ctdbase.org/detail.go?type=gene&acc=3800,,,3800,KIF5C,9606,Homo sapiens (human),Enzalutamide results in decreased expression of KIF5C mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
30,2012809,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,3817.0,KLK2,https://ctdbase.org/detail.go?type=gene&acc=3817,,,3817,KLK2,9606,Homo sapiens (human),Enzalutamide results in decreased expression of KLK2 mRNA,,,PMID:29581250,https://www.ncbi.nlm.nih.gov/pubmed/29581250,29581250,,
31,2012810,15951529,Comparative Toxicogenomics Database (CTD),Enzalutamide,C540278,enzalutamide,https://ctdbase.org/detail.go?type=chem&acc=C540278,354.0,KLK3,https://ctdbase.org/detail.go?type=gene&acc=354,,,354,KLK3,9606,Homo sapiens (human),Enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of KLK3 protein]|nvp-BHG712 promotes the reaction [enzalutamide results in decreased expression of KLK3 protein]|[enzalutamide co-treated with NVP-BHG712] results in decreased expression of KLK3 protein|enzalutamide promotes the reaction [EPHB4 protein affects the expression of KLK3 protein]|enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of KLK3 mrna]|[enzalutamide co-treated with NVP-BHG712] results in decreased expression of KLK3 mRNA,,,PMID:32184358,https://www.ncbi.nlm.nih.gov/pubmed/32184358,32184358,,
32,2030339,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2625.0,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625,GATA3,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of GATA3 mRNA,,,PMID:19031437,https://www.ncbi.nlm.nih.gov/pubmed/19031437,19031437,,
33,2030340,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2626.0,GATA4,https://ctdbase.org/detail.go?type=gene&acc=2626,,,2626,GATA4,10090,Mus musculus (house mouse),Tamoxifen results in decreased expression of GATA4 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
34,2030341,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,57798.0,GATAD1,https://ctdbase.org/detail.go?type=gene&acc=57798,,,57798,GATAD1,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GATAD1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
35,2030342,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2628.0,GATM,https://ctdbase.org/detail.go?type=gene&acc=2628,,,2628,GATM,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GATM mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
36,2030343,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2630.0,GBA1LP,https://ctdbase.org/detail.go?type=gene&acc=2630,,,2630,GBA1LP,9606,Homo sapiens (human),Tamoxifen affects the expression of GBA1LP mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
37,2030344,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,115361.0,GBP4,https://ctdbase.org/detail.go?type=gene&acc=115361,,,115361,GBP4,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GBP4 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
38,2030345,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,163351.0,GBP6,https://ctdbase.org/detail.go?type=gene&acc=163351,,,163351,GBP6,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GBP6 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
39,2030346,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,163351.0,GBP6,https://ctdbase.org/detail.go?type=gene&acc=163351,,,163351,GBP6,10090,Mus musculus (house mouse),Tamoxifen results in decreased expression of GBP6 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
40,2030347,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,25801.0,GCA,https://ctdbase.org/detail.go?type=gene&acc=25801,,,25801,GCA,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GCA mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
41,2030348,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2645.0,GCK,https://ctdbase.org/detail.go?type=gene&acc=2645,,,2645,GCK,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GCK mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
42,2030363,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2729.0,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729,GCLC,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GCLC mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
43,2030364,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,100504486.0,GDAP10,https://ctdbase.org/detail.go?type=gene&acc=100504486,,,100504486,Gdap10,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GDAP10 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
44,2030365,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2662.0,GDF10,https://ctdbase.org/detail.go?type=gene&acc=2662,,,2662,GDF10,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GDF10 mRNA,,,PMID:17555576|PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/17555576|https://www.ncbi.nlm.nih.gov/pubmed/20937368,17555576|20937368,,
45,2030366,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9518.0,GDF15,https://ctdbase.org/detail.go?type=gene&acc=9518,,,9518,GDF15,9606,Homo sapiens (human),GDF15 protein results in decreased susceptibility to tamoxifen,,,PMID:22615612,https://www.ncbi.nlm.nih.gov/pubmed/22615612,22615612,,
46,2030367,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9518.0,GDF15,https://ctdbase.org/detail.go?type=gene&acc=9518,,,9518,GDF15,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GDF15 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
47,2030368,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9518.0,GDF15,https://ctdbase.org/detail.go?type=gene&acc=9518,,,9518,GDF15,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of GDF15 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
48,2030369,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9573.0,GDF3,https://ctdbase.org/detail.go?type=gene&acc=9573,,,9573,GDF3,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GDF3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
49,2030370,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,392255.0,GDF6,https://ctdbase.org/detail.go?type=gene&acc=392255,,,392255,GDF6,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of GDF6 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
50,2030371,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2661.0,GDF9,https://ctdbase.org/detail.go?type=gene&acc=2661,,,2661,GDF9,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of GDF9 mRNA,,,PMID:22841776,https://www.ncbi.nlm.nih.gov/pubmed/22841776,22841776,,
51,2030372,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,79153.0,GDPD3,https://ctdbase.org/detail.go?type=gene&acc=79153,,,79153,GDPD3,9606,Homo sapiens (human),Tamoxifen results in increased expression of GDPD3 mRNA,,,PMID:15342952|PMID:17175557|PMID:17567588,https://www.ncbi.nlm.nih.gov/pubmed/15342952|https://www.ncbi.nlm.nih.gov/pubmed/17175557|https://www.ncbi.nlm.nih.gov/pubmed/17567588,15342952|17175557|17567588,,
52,2030380,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2669.0,GEM,https://ctdbase.org/detail.go?type=gene&acc=2669,,,2669,GEM,9606,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol results in increased expression of GEM mrna],,,PMID:24758408,https://www.ncbi.nlm.nih.gov/pubmed/24758408,24758408,,
53,2030381,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2669.0,GEM,https://ctdbase.org/detail.go?type=gene&acc=2669,,,2669,GEM,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of GEM mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
54,2030382,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8487.0,GEMIN2,https://ctdbase.org/detail.go?type=gene&acc=8487,,,8487,GEMIN2,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GEMIN2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
55,2030383,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2670.0,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670,GFAP,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GFAP mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
56,2030384,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2670.0,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670,GFAP,10090,Mus musculus (house mouse),Tamoxifen inhibits the reaction [bisphenol A results in increased expression of GFAP protein],,,PMID:16860915,https://www.ncbi.nlm.nih.gov/pubmed/16860915,16860915,,
57,2030385,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2672.0,GFI1,https://ctdbase.org/detail.go?type=gene&acc=2672,,,2672,GFI1,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of GFI1 mRNA,,,PMID:19031437,https://www.ncbi.nlm.nih.gov/pubmed/19031437,19031437,,
58,2030386,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,85476.0,GFM1,https://ctdbase.org/detail.go?type=gene&acc=85476,,,85476,GFM1,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GFM1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
59,2030387,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2673.0,GFPT1,https://ctdbase.org/detail.go?type=gene&acc=2673,,,2673,GFPT1,9606,Homo sapiens (human),Tamoxifen results in increased expression of GFPT1 mRNA,,,PMID:15604281,https://www.ncbi.nlm.nih.gov/pubmed/15604281,15604281,,
60,2030388,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2675.0,GFRA2,https://ctdbase.org/detail.go?type=gene&acc=2675,,,2675,GFRA2,9606,Homo sapiens (human),Tamoxifen inhibits the reaction [[estradiol co-treated with EGF protein] results in increased expression of GFRA2 mrna]|tamoxifen inhibits the reaction [estradiol results in increased expression of GFRA2 mrna],,,PMID:24758408,https://www.ncbi.nlm.nih.gov/pubmed/24758408,24758408,,
61,2030389,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,23163.0,GGA3,https://ctdbase.org/detail.go?type=gene&acc=23163,,,23163,GGA3,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GGA3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
62,2030390,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,79017.0,GGCT,https://ctdbase.org/detail.go?type=gene&acc=79017,,,79017,GGCT,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GGCT mRNA,,,PMID:17555576|PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/17555576|https://www.ncbi.nlm.nih.gov/pubmed/20937368,17555576|20937368,,
63,2030391,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,79017.0,GGCT,https://ctdbase.org/detail.go?type=gene&acc=79017,,,79017,GGCT,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of GGCT mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
64,2030392,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,14599.0,GH,https://ctdbase.org/detail.go?type=gene&acc=14599,,,14599,Gh,10090,Mus musculus (house mouse),Tamoxifen inhibits the reaction [estradiol results in increased expression of GH mrna],,,PMID:22349083,https://www.ncbi.nlm.nih.gov/pubmed/22349083,22349083,,
65,2030393,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2688.0,GH1,https://ctdbase.org/detail.go?type=gene&acc=2688,,,2688,GH1,10116,Rattus norvegicus (Norway rat),Tamoxifen results in decreased secretion of GH1 protein|tamoxifen promotes the reaction [SST protein results in decreased secretion of GH1 protein],,,PMID:1350760,https://www.ncbi.nlm.nih.gov/pubmed/1350760,1350760,,
66,2030394,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,27069.0,GHITM,https://ctdbase.org/detail.go?type=gene&acc=27069,,,27069,GHITM,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GHITM mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
67,2030395,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2690.0,GHR,https://ctdbase.org/detail.go?type=gene&acc=2690,,,2690,GHR,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GHR mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
68,2030396,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,83408.0,GIMAP3,https://ctdbase.org/detail.go?type=gene&acc=83408,,,83408,Gimap3,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GIMAP3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
69,2030397,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2695.0,GIP,https://ctdbase.org/detail.go?type=gene&acc=2695,,,2695,GIP,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of GIP mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
70,2030398,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9815.0,GIT2,https://ctdbase.org/detail.go?type=gene&acc=9815,,,9815,GIT2,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GIT2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
71,2030399,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2697.0,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697,GJA1,9606,Homo sapiens (human),Tamoxifen affects the expression of GJA1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
72,2030400,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2697.0,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697,GJA1,10090,Mus musculus (house mouse),Tamoxifen affects the expression of GJA1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
73,2030401,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2697.0,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697,GJA1,10090,Mus musculus (house mouse),Tamoxifen results in increased expression of GJA1 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
74,2012802,20855152,Drug Gene Interaction database (DGIdb),4-(3-aminophenyl)-N-(4-methoxyphenyl)pyrimidin-2-amine,,CHEMBL:CHEMBL1406948,https://www.dgidb.org/drugs/chembl:CHEMBL1406948,,BAZ2B,https://www.dgidb.org/genes/hgnc:963,,,29994,BAZ2B,9606,Homo sapiens (human),,,,,,,,
75,2012803,20855152,Drug Gene Interaction database (DGIdb),4-(3-aminophenyl)-N-(4-methoxyphenyl)pyrimidin-2-amine,,CHEMBL:CHEMBL1406948,https://www.dgidb.org/drugs/chembl:CHEMBL1406948,,SMAD3,https://www.dgidb.org/genes/hgnc:6769,,,4088,SMAD3,9606,Homo sapiens (human),,,,,,,,
76,2012804,20855152,Drug Gene Interaction database (DGIdb),4-(3-aminophenyl)-N-(4-methoxyphenyl)pyrimidin-2-amine,,CHEMBL:CHEMBL1406948,https://www.dgidb.org/drugs/chembl:CHEMBL1406948,,NPC1,https://www.dgidb.org/genes/hgnc:7897,,,4864,NPC1,9606,Homo sapiens (human),,,,,,,,
77,2012805,21023902,IUPHAR/BPS Guide to PHARMACOLOGY,"2-bromo-4,5-dimethoxy-N-[3-[(3R)-1-methylpyrrolidin-3-yl]oxy-4-(trifluoromethyl)phenyl]benzenesulfonamide",2165,SB-706375,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2165,365.0,UT receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=365,Q8VIH9,Urotensin-2 receptor,217369,Uts2r,10090,Mus musculus (house mouse),Antagonist,pKi,7.7,PMID:15852036,https://www.ncbi.nlm.nih.gov/pubmed/15852036,15852036,,
78,2030322,21428971,BindingDB,"4-Methoxy-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide",36420,"4-Methoxy-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide, 51",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36420,4399.0,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337,PLD1,9606,Homo sapiens (human),,IC50 (nM),>20000,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
79,2030323,21428971,BindingDB,"4-Methoxy-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide",36420,"4-Methoxy-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide, 51",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36420,4399.0,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337,PLD1,9606,Homo sapiens (human),,IC50 (nM),>20000,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
80,2030324,21428971,BindingDB,"4-Methoxy-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide",36420,"4-Methoxy-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide, 51",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36420,4399.0,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337,PLD1,9606,Homo sapiens (human),,IC50 (nM),15000,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
81,2030325,21521602,BindingDB,"6-Nitro-1,2-benzoxazol-3-ol",23178,"6-nitro-1,2-benzoxazol-3-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23178,2337.0,D-amino-acid oxidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2337,P00371,D-amino-acid oxidase,397134,DAO,9823,Sus scrofa (pig),,IC50 (nM),722,PMID:18507366|DOI:10.1021/jm800200u,https://www.ncbi.nlm.nih.gov/pubmed/18507366|https://doi.org/10.1021/jm800200u,18507366,10.1021/jm800200u,
82,2030326,24971389,BindingDB,"({4-[2-(Methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(pyridin-3-yl)ethyl]amine",24861,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(pyridin-3-yl)ethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24861,527.0,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208,AKT2,9606,Homo sapiens (human),,IC50 (nM),1160,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
83,2030327,24971389,BindingDB,"({4-[2-(Methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(pyridin-3-yl)ethyl]amine",24861,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(pyridin-3-yl)ethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24861,513.0,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207,AKT1,9606,Homo sapiens (human),,IC50 (nM),90,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
84,2030328,24971390,BindingDB,"[3-(1H-imidazol-1-yl)propyl]({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amine",24862,"Pyridopyrimidine, 12g",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24862,513.0,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207,AKT1,9606,Homo sapiens (human),,IC50 (nM),137,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
85,2030329,24971390,BindingDB,"[3-(1H-imidazol-1-yl)propyl]({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amine",24862,"Pyridopyrimidine, 12g",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24862,527.0,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208,AKT2,9606,Homo sapiens (human),,IC50 (nM),1514,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
86,2030330,24971391,BindingDB,"methyl({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1H-pyrazol-4-yl)ethyl]amine",24863,"Pyridopyrimidine, 12h",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24863,527.0,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208,AKT2,9606,Homo sapiens (human),,IC50 (nM),17470,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
87,2030331,24971391,BindingDB,"methyl({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1H-pyrazol-4-yl)ethyl]amine",24863,"Pyridopyrimidine, 12h",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24863,513.0,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207,AKT1,9606,Homo sapiens (human),,IC50 (nM),1521,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
88,2030332,24971392,BindingDB,"[2-(5-methyl-1H-1,2,4-triazol-3-yl)ethyl]({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amine",24864,"Pyridopyrimidine, 12i",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24864,513.0,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207,AKT1,9606,Homo sapiens (human),,IC50 (nM),162,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
89,2030357,24971392,BindingDB,"[2-(5-methyl-1H-1,2,4-triazol-3-yl)ethyl]({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amine",24864,"Pyridopyrimidine, 12i",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24864,527.0,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208,AKT2,9606,Homo sapiens (human),,IC50 (nM),1792,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
90,2030358,24971393,BindingDB,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(5-phenyl-1H-1,2,4-triazol-3-yl)ethyl]amine",24865,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(5-phenyl-1H-1,2,4-triazol-3-yl)ethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24865,527.0,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208,AKT2,9606,Homo sapiens (human),,IC50 (nM),494,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
91,2030359,24971393,BindingDB,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(5-phenyl-1H-1,2,4-triazol-3-yl)ethyl]amine",24865,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(5-phenyl-1H-1,2,4-triazol-3-yl)ethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24865,513.0,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207,AKT1,9606,Homo sapiens (human),,IC50 (nM),63,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
92,2030360,24971394,BindingDB,"1-[1-({4-[3-phenyl-5-(1,3-thiazol-2-yl)pyridin-2-yl]phenyl}methyl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",24894,"1-[1-({4-[3-phenyl-5-(1,3-thiazol-2-yl)pyridin-2-yl]phenyl}methyl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24894,527.0,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208,AKT2,9606,Homo sapiens (human),,IC50 (nM),64,PMID:18294842|DOI:10.1016/j.bmcl.2007.12.040,https://www.ncbi.nlm.nih.gov/pubmed/18294842|https://doi.org/10.1016/j.bmcl.2007.12.040,18294842,10.1016/j.bmcl.2007.12.040,
93,2030361,24971394,BindingDB,"1-[1-({4-[3-phenyl-5-(1,3-thiazol-2-yl)pyridin-2-yl]phenyl}methyl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",24894,"1-[1-({4-[3-phenyl-5-(1,3-thiazol-2-yl)pyridin-2-yl]phenyl}methyl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24894,513.0,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207,AKT1,9606,Homo sapiens (human),,IC50 (nM),264,PMID:18294842|DOI:10.1016/j.bmcl.2007.12.040,https://www.ncbi.nlm.nih.gov/pubmed/18294842|https://doi.org/10.1016/j.bmcl.2007.12.040,18294842,10.1016/j.bmcl.2007.12.040,
94,2030362,24971395,BindingDB,"3-{[(4-Chlorophenyl)methyl]sulfanyl}-5-[(methylcarbamoyl)amino]-1,2-thiazole-4-carboxamide",24898,"3-{[(4-chlorophenyl)methyl]sulfanyl}-5-[(methylcarbamoyl)amino]-1,2-thiazole-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24898,3688.0,High affinity nerve growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3688,P04629,High affinity nerve growth factor receptor,4914,NTRK1,9606,Homo sapiens (human),,IC50 (nM),7,PMID:16632359|DOI:10.1016/j.bmcl.2006.04.003,https://www.ncbi.nlm.nih.gov/pubmed/16632359|https://doi.org/10.1016/j.bmcl.2006.04.003,16632359,10.1016/j.bmcl.2006.04.003,
95,2030349,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,10520.0,ZNF211,https://ctdbase.org/detail.go?type=gene&acc=10520,,,10520,ZNF211,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF211 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
96,2030350,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7988.0,ZNF212,https://ctdbase.org/detail.go?type=gene&acc=7988,,,7988,ZNF212,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF212 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
97,2030351,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7764.0,ZNF217,https://ctdbase.org/detail.go?type=gene&acc=7764,,,7764,ZNF217,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF217 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
98,2030352,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7673.0,ZNF222,https://ctdbase.org/detail.go?type=gene&acc=7673,,,7673,ZNF222,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF222 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
99,2030353,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7766.0,ZNF223,https://ctdbase.org/detail.go?type=gene&acc=7766,,,7766,ZNF223,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF223 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
100,2030354,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7767.0,ZNF224,https://ctdbase.org/detail.go?type=gene&acc=7767,,,7767,ZNF224,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF224 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
101,2030355,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7768.0,ZNF225,https://ctdbase.org/detail.go?type=gene&acc=7768,,,7768,ZNF225,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF225 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
102,2030356,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7769.0,ZNF226,https://ctdbase.org/detail.go?type=gene&acc=7769,,,7769,ZNF226,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF226 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
103,2030333,25218593,BindingDB,"2-((2-((2-Methyl-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzamide",27818,"2-[(2-{[2-methyl-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27818,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),5,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
104,2030334,25218594,BindingDB,"2-[(2-{[4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27819,"2-[(2-{[4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27819,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),1.6,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
105,2030335,25218595,BindingDB,"2-[(2-{[2-fluoro-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27820,"2-[(2-{[2-fluoro-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27820,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),1.6,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
106,2030336,25218596,BindingDB,"2-[(2-{[4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)-2-(trifluoromethyl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27821,"2-[(2-{[4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)-2-(trifluoromethyl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27821,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),20,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
107,2030337,25218597,BindingDB,"2-[(2-{[2-methoxy-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27822,"2-[(2-{[2-methoxy-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27822,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),0.6,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
108,2030338,25218598,BindingDB,"4-fluoro-2-[(2-{[2-methoxy-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27823,"4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27823,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),0.8,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
109,2030373,25218599,BindingDB,"4-fluoro-2-[(2-{[2-(propan-2-yloxy)-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27824,"4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27824,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),3.2,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
110,2030374,25218600,BindingDB,"4-Fluoro-2-((2-((2-methoxy-4-(1-propylpiperidin-3-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzamide",27825,"4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27825,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),0.4,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
111,2030375,25218601,BindingDB,"4-fluoro-2-[(2-{[2-methoxy-4-(1-propylpiperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27826,"4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27826,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),0.3,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
112,2030376,25218602,BindingDB,"4-fluoro-2-[(2-{[2-methoxy-4-(4-propylpiperazin-1-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27827,"4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27827,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),1.6,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
113,2030377,25218603,BindingDB,"4-fluoro-2-{[2-({2-methoxy-4-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27828,"4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine, 11",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27828,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),0.8,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
114,2030378,25218604,BindingDB,"4-fluoro-2-[(2-{[2-methoxy-4-(morpholin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27829,"4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27829,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),1.6,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
115,2030379,25218605,BindingDB,"2-fluoro-6-{[2-({2-methoxy-4-[4-(propan-2-yl)piperazin-1-yl]phenyl}(methyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27830,"2-fluoro-6-{[2-({2-methoxy-4-[4-(propan-2-yl)piperazin-1-yl]phenyl}(methyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27830,4953.0,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480,IGF1R,9606,Homo sapiens (human),,IC50 (nM),50,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
